| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1368854 | Bioorganic & Medicinal Chemistry Letters | 2014 | 4 Pages |
Abstract
Peptidic α-ketoamides have been developed as inhibitors of the malarial protease PfSUB1. The design of inhibitors was based on the best known endogenous PfSUB1 substrate sequence, leading to compounds with low micromolar to submicromolar inhibitory activity. SAR studies were performed indicating the requirement of an aspartate mimicking the P1′ substituent and optimal P1–P4 length of the non-prime part. The importance of each of the P1–P4 amino acid side chains was investigated, revealing crucial interactions and size limitations.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Samir S. Kher, Maria Penzo, Simone Fulle, Paul W. Finn, Michael J. Blackman, Aigars Jirgensons,